Substantia innominata: MR findings in Parkinson’s disease

被引:0
|
作者
Hirobumi Oikawa
Makoto Sasaki
Shigeru Ehara
Takashi Abe
机构
[1] Iwate Medical University,High Field Magnetic Resonance Imaging Research Institute
[2] Iwate Medical University,Department of Neurology
[3] Iwate Medical University,undefined
来源
Neuroradiology | 2004年 / 46卷
关键词
Substantia innominata; Parkinson’s disease; Mini-mental-status examination; Nucleus basalis of Meynert;
D O I
暂无
中图分类号
学科分类号
摘要
To elucidate MR imaging changes of the substantia innominata in Parkinson’s disease (PD), using a 1.5-T superconductive MR unit, the thickness of the substantia innominata was measured on coronal thin-section images in 44 PD patients and 20 age-matched control subjects. We also evaluated the correlation between the thickness of the substantia innominata and mental status in PD patients. Mean thickness of the substantia innominata was 2.3 mm in PD patients, and 2.5 mm in control subjects. Thinning of the substantia innominata was statistically significant in PD patients compared with control subjects, although there were large overlaps. Among the PD patients, thinning was remarkable in cases with dementia. A positive correlation between thickness of substantia innominata and score of Mini-Mental-Status-Examination was also observed in PD patients. Atrophy of the substantia innominata was demonstrated, especially in PD patients with cognitive impairment, on coronal MR images, and this is compatible with the previous pathological reports.
引用
收藏
页码:817 / 821
页数:4
相关论文
共 50 条
  • [41] Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease
    Tomas, Monica
    Martinez-Alonso, Emma
    Martinez-Martinez, Narcisa
    Cara-Esteban, Mireia
    Martinez-Menarguez, Jose A.
    HISTOLOGY AND HISTOPATHOLOGY, 2021, 36 (01) : 47 - 60
  • [42] MICROGLIAL ACTIVATION BEYOND THE SUBSTANTIA NIGRA IN PARKINSON'S DISEASE
    Doorn, K.
    Lucassen, P. J.
    Bol, J. G. J.
    Drukarch, B.
    van de Berg, W. D. J.
    van Dam, A-M.
    GLIA, 2013, 61 : S166 - S167
  • [43] Proteome analysis of human substantia nigra in Parkinson's disease
    Cornelius J Werner
    Roland Heyny-von Haussen
    Gerhard Mall
    Sabine Wolf
    Proteome Science, 6
  • [44] Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
    R. K. B. Pearce
    A. Owen
    S. Daniel
    P. Jenner
    C. D. Marsden
    Journal of Neural Transmission, 1997, 104 : 661 - 677
  • [45] Quantitative Susceptibility Mapping of the Substantia Nigra in Parkinson's Disease
    Zhao, Xinxin
    An, Hedi
    Liu, Tian
    Shen, Nan
    Bo, Binshi
    Zhang, Zhuwei
    Weng, Pengfei
    Chen, Meining
    Pei, Mengchao
    Wang, Yi
    Huang, Dongya
    Li, Jianqi
    APPLIED MAGNETIC RESONANCE, 2017, 48 (06) : 533 - 544
  • [46] Substantia nigra hyperechogenicity in Parkinson's disease motor phenotypes
    Toomsoo, T.
    Pool, A. -H.
    Liepelt-Scarfone, I.
    Kadastik-Eerme, L.
    Asser, T.
    Berg, D.
    Taba, P.
    MOVEMENT DISORDERS, 2016, 31 : S409 - S409
  • [47] Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease
    Ambrosius, W.
    Michalak, S.
    Owecki, M.
    Lukasik, M.
    Florczak-Wyspianska, J.
    Kozubski, W.
    FOLIA MORPHOLOGICA, 2014, 73 (03) : 267 - 271
  • [48] Proteome analysis of human substantia nigra in Parkinson's disease
    Werner, C. J.
    Heyny-von Haussen, R.
    Mall, G.
    Wolf, S.
    MOVEMENT DISORDERS, 2007, 22 : S201 - S201
  • [49] Proteomic analysis of the substantia nigra of Parkinson's disease patients
    Zhang, S.
    Shao, W.
    Zhou, Q.
    Fu, N.
    Yin, Y.
    Rong, R.
    Zhou, J.
    MOVEMENT DISORDERS, 2011, 26 : S31 - S31
  • [50] Proteasomal function is impaired in substantia nigra in Parkinson's disease
    McNaught, KSP
    Jenner, P
    NEUROSCIENCE LETTERS, 2001, 297 (03) : 191 - 194